vitiligo

How to Diagnose and Treat Hypopigmentation with Dr. Hamzavi
hypopigmentation
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Iltefat Hamzavi, dermatologist with Henry Ford Health and associate professor of dermatology at Wayne State University School of Medicine. Dr. Hamzavi addresses how to diagnose and treat hypopigmentation, a catch-all for pigmentary conditions where the pigment is not too dark or complete …
Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
Tofacitinib
by NEXT STEPS IN DERM TEAM on
INTRODUCTION Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib …
Thyroid Dysfunction – Friday Pop Quiz 1/13/2023
by NEXT STEPS IN DERM TEAM on
What mutation is responsible for this clinical presentation in a patient with both thyroid dysfunction and chronic candidal infections? A. Autoimmune regulator (AIRE) B. Phosphatase and tensin homolog (PTEN) C. Tyrosine related protein 1 (TRP1) D. Fumarate hydratase (FH) E. Lysosomal trafficking regulator (LYST)   To find out the correct answer and read the explanation, …
Diagnosing & Treating Vitiligo in 2022 and What’s To Come
vitiligo
by Shanthi Narla, MD on
As a former vitiligo clinical trials research fellow, I have attended more than my fair share of presentations on vitiligo. Yet, I am amazed at how each additional lecture continues to teach me new and exciting concepts and treatment options for vitiligo. Dr. Seemal Desai’s lecture at the 2022 Skin of Color Update Conference was no exception to this rule. During the SOCU Conference held in Ne …